Noble metal alloy-coated latex versus silicone Foley catheter in short-term catheterization: A randomized controlled study

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 4, 2011, Pages 258-264

  Stenzelius, Karin ^a   Persson, Siv ^a   Olsson, Ulla Britt ^a   Stjrneblad, Monica ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Hssleholm Hospital   (Sweden)

Author keywords

Bacteriuria; Catheter associated urinary tract infection; Noble metal alloy coated Foley catheter; Orthopaedic surgery; Randomized controlled trial; Silicone Foley catheter

Indexed keywords

ALLOY; CLOXACILLIN; LATEX; SILICONE;

ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIURIA; BALLOON CATHETER; BLOODSTREAM INFECTION; BURNING SENSATION; CATHETER INFECTION; CATHETER REMOVAL; COMPARATIVE STUDY; ELECTIVE SURGERY; FEMALE; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; INDWELLING CATHETER; MAJOR CLINICAL STUDY; MALE; NOBLE ALLOY COATED LATEX FOLEY CATHETER; OBESITY; ORTHOPEDIC SURGERY; PAIN; POLYURIA; PRIORITY JOURNAL; PROSTHESIS INFECTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SILICONE FOLEY CATHETER; SINGLE DRUG DOSE; SLEEP DISORDER; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE CULTURE;

AGED; BACTERIURIA; BALLOON DILATION; CATHETERS, INDWELLING; FEMALE; GOLD; HUMANS; INCIDENCE; LATEX; MALE; METALS; MIDDLE AGED; OBESITY; ORTHOPEDIC PROCEDURES; PALLADIUM; RISK FACTORS; SEX FACTORS; SILICONES; SILVER; URINARY TRACT INFECTIONS;

EID: 80051752419     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2011.560007     Document Type: Article

References (25)

1. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160-6.
2. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis 1983;148:57-62. (Pubitemid 13039312)
3. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000;28:68-75. (Pubitemid 30120943)
4. Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med 2002;165:1475-9. (Pubitemid 34606660)
5. Platt R, Polk BF, Murdock B, Rosner B. Reduction of mortality associated with nosocomial urinary tract infection. Lancet 1983;1:893-7. (Pubitemid 13112148)
6. Grabe M, Bjerklund-Johansson TE, Botto H, Cek M, Naber KG, Tenke P, et al. Guidelines on urological infections. European Association of Urology; 2010.
7. Winter M, Helms B, Harrington L, Luquire R, McVay T, Rhodes N. Eliminating catheter-associated urinary tract infections: Part I. Avoid catheter use. J Healthc Qual 2009;31:8-12.
8. Rhodes N, McVay T, Harrington L, Luquire R, Winter M, Helms B. Eliminating catheter-associated urinary tract infections: Part II. Limit duration of catheter use. J Healthc Qual 2009;31:13-17.
9. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2004 (1): CD004013.
10. Davenport K, Keeley FX. Evidence for the use of silveralloy-coated urethral catheters. J Hosp Infect 2005;60:298-303. (Pubitemid 40932082)
11. Fryklund B, Pettersson B, Svenson G, Burman LG. [A closed system for bladder drainage via an indwelling catheter reduces the risks of bacteriuria]. Lakartidningen 1991;88:738, 40-1.
12. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294-8.
13. Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 2004;32:445-50. (Pubitemid 39574468)
14. Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2008 (2): CD004013.
15. Jakobsson L. Indwelling catheter treatment and healthrelated quality of life in men with prostate cancer in comparison with men with benign prostatic hyperplasia. Scand J Caring Sci 2002;16:264-71. (Pubitemid 35005841)
16. Altman D. Practical statistics for medical research. London: Chapman & Hall; 1999.
17. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate data analysis. London: Prentice-Hall International; 1998.
18. Garibaldi RA, Mooney BR, Epstein BJ, Britt MR. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982;3:466-70.
19. Hartstein AI, Garber SB, Ward TT, Jones SR, Morthland VH. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infect Control 1981;2:380-6.
20. Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med 2000;160:673-7. (Pubitemid 30140417)
21. Platt R. Adverse consequences of asymptomatic urinary tract infections in adults. Am J Med 1987;82(6 B):47-52.
22. Platt R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977-85. (Pubitemid 17207266)
23. Malmsten UG, Molander U, Peeker R, Irwin DE, Milsom I. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol 2010;58:149-56.
24. Milsom I. Lower urinary tract symptoms in women. Curr Opin Urol 2009;19:337-41.
25. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11:609-22. (Pubitemid 27445475)